Abstracts A155 infusion etc.). In measuring the number of tests conducted and time per test, i.e. laboratory effi ciency, we found that the use of regadenoson versus adenosine and dipyridamole could reduce the overall test time by 18 and 17 minutes respectively. Assuming a baseline of 39 pharm-stress MPI tests per week for both adenosine and dipyridamole, the time saved per test using regadenoson translates into potentially servicing additional 330-366 patients per year. CONCLUSIONS: Due to its weight-independent calculation and its administration via a rapid injection, the use of regadenoson may result in direct savings of laboratory personnel time and labor and the potential for increased patient throughput versus adenosine or dipyridamole. These time savings could lead to increased laboratory effi ciencies (scheduling additional tests per week or reorganizing staff more effi ciently).
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IMPACT OF MEDICATION ADHERENCE ON CARDIOVASCULAR DISEASE-RELATED HEALTH CARE COST AMONG PATIENTS TREATED WITH FIXED DOSE COMBINATION VERSUS MULTI-PILL COMBINATION THERAPIES AMONG DYSLIPIDEMIA PATIENTS IN A MANAGED CARE POPULATION
Balu S 1 , Simko RJ 1 , Webb SF 1 , Yu J 2 , Quimbo R 2 , Cziraky MJ 2 1 Abbott Laboratories, Abbott Park, IL, USA, 2 HealthCore, Inc., Wilmington, DE, USA OBJECTIVES: Assess the impact of optimal medication adherence on total cardiovascular disease (CVD)-related total health care cost (THC) among dyslipidemia patients initiating fi xed dose combination (FDC) The purpose of this study was to test the theoretical model of whether patient's effi cacy expectations and outcome expectations mediate the relationship between health literacy and medication adherence. In addition, the relationships between patients' demographic variables and their health literacy skills, outcome expectations, effi cacy expectations and medication adherence were evaluated METHODS: A survey composed of four validated instruments along with questions related to patient's demographic information was utilized. The four validated instruments assessed functional health literacy (S-TOFHLA), medication related outcome expectations and effi cacy expectations and medication adherence (MARS). The questionnaire was pretested by conducting a pilot study of 21 patients with hypertension at a community health clinic. RESULTS: In the main study 200 patients with hypertension completed the self-administered survey. Path analysis was used to test the theoretical model. Age had statistically signifi cant associations with health literacy scores (ñ 0.17, p 0.015), effi cacy expectations (ñ 0.23, p 0.004), and medication adherence (ñ 0.27, p 0.0001). In addition, number of prescriptions taken daily and insurance (t 5.30, p 0.001) had a statistically signifi cant association with medication adherence (ñ 0.16, p 0.024). Health literacy was only variable that was statistically correlated with income (ñ 0.21, p 0.003) and level of education (ñ 0.29, p 0.001). Path analysis indicated that medication adherence was signifi cantly associated with age and effi cacy expectations, which also was related to health literacy level, age and income. Health literacy was also a signifi cant predictor of outcome expectations. Gender, level of education, and income were the only demographic variables signifi cantly associated with health literacy scores.
CONCLUSIONS:
The results of the study suggested that health literacy had an impact on medication adherence through effi cacy expectations.
PCV77 EVALUATION OF AN EDUCATIONAL ANTIHYPERTENSIVE MEDICATION ADHERENCE TOOL: IMPACT ON ANTIHYPERTENSIVE ADHERENCE AND BLOOD PRESSURE CONTROL
Bui CN 1 , Hanson KA 2 , Prasla K 1 , Godley PJ 1 , Frech-Tamas F 2 , Rascati KL 3 1 Scott and White Health System, Temple, TX, USA, 2 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA, 3 University of Texas at Austin, Austin, TX, USA OBJECTIVES: Poor adherence to antihypertensive therapy increases patient risks of cardiovascular events. The objective of this study was to measure the effectiveness of an individualized educational program on medication adherence and blood pressure (BP) control. METHODS: This was a six-month, longitudinal study with a prospectively identifi ed intervention group and a retrospective control group. The Scott & White Health Plan enrollment and claim databases and EMR were utilized to identify continuously enrolled patients aged 18 years or older, diagnosed with hypertension, and treated with valsartan, aliskiren, or a fi xed-dose combination of valsartan/hydrochlorothiazide or amlodipine/valsartan for at least three months prior to study enrollment. Patients meeting the inclusion criteria were invited to participate in the prospective intervention arm of the study, while those with geographic limitation served as controls. The intervention group received monthly personalized information about hypertension and treatment. A power analysis determined 150 participants would be required in each arm to detect a 3% change in MPR. The intervention and control groups were matched based on demographic characteristics and Charlson Comorbidity Index score. All interval data were analyzed using paired t-tests, while categorical data were analyzed using chi-square tests. RESULTS: A total of 159 patients enrolled into the study (60% female; mean [SD] 
